Short-acting Analog Insulins No Longer Paid for by German Government

n Germany, the Federal Government has decided to discontinue the reimbursement of short-acting analogue insulins for people with type 1 diabetes. This follows the conclusions of an evidence-based evaluation carried out by the German Institute for Quality and Cost Effectiveness in Health Care Sector (IQWiG) that was submitted to the German Joint Government Committee (G-BA). As the evaluation concluded that these insulins had no added value compared to human insulin, the decision to discontinue reimbursement was based purely on economic grounds.  For more info on this international news story… check out the International Diabetes Federation.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s